The CRISPR Patent Decision Didn't Get the Science Right

The CRISPR Patent Decision Didn't Get the Science Right
AP Photo/Susan Walsh

The CRISPR patent dispute between the University of California, Berkeley, and the Broad Institute is finally over. As almost everyone following the case predicted, the U.S. Court of Appeals for the Federal Circuit affirmed Monday the U.S. patent office's decision that there was “no interference-in-fact” between UC Berkeley's patent application and more than a dozen Broad patents.

Read Full Article »
Comment
Show comments Hide Comments

Related Articles